In vitro study of momordin Ic in improving atopic dermatitis by regulating claudin-1/MyD88 and targeting NLRP3
Atopic dermatitis (AD) is a non-infectious inflammatory skin disease characterized by persistent itching of the skin, and it has become a global health problem with increasing incidence and complex pathogenesis. Momordin Ic (MMI) is a triterpenoid saponin that has anti-inflammatory effect and may pl...
Saved in:
Main Authors: | Ying Guo (Author), Litao Wang (Author), Jing Zhang (Author), Tingting Jing (Author), Lefan Fu (Author), Guoying Miao (Author) |
---|---|
Format: | Book |
Published: |
Polskie Towarzystwo Farmaceutyczne,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
by: Junbin Chen, et al.
Published: (2020) -
Arctiin Alleviates Atopic Dermatitis Against Inflammation and Pyroptosis Through Suppressing TLR4/MyD88/NF-κB and NLRP3/Caspase-1/GSDMD Signaling Pathways
by: Li J, et al.
Published: (2024) -
Oxymatrine Downregulates TLR4, TLR2, MyD88, and NF-κB and Protects Rat Brains against Focal Ischemia
by: Hongguang Fan, et al.
Published: (2009) -
MyD88 signalling is critical in the development of pancreatic cancer cachexia
by: Xinxia Zhu, et al.
Published: (2019) -
LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing
by: Ni Li, et al.
Published: (2022)